Free shipping on all orders over $ 500

Chloroquinoxaline sulfonamide

Cat. No. M30983

All AbMole products are for research use only, cannot be used for human consumption.

Chloroquinoxaline sulfonamide Structure
Synonym:

Chloroquinoxaline; NSC-339004

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

Chloroquinoxaline sulfonamide (Chloroquinoxaline), a structural analogue of sulfaquinoxaline, is a topoisomerase II alpha/beta poison. Chloroquinoxaline sulfonamide is used to control coccidiosis in poultry, rabbit, sheep, and cattle. Antitumor activity.

Chemical Information
Molecular Weight 334.78
Formula C14H11ClN4O2S
CAS Number 97919-22-7
Form Solid
Solubility (25°C) DMSO 125 mg/mL (ultrasonic)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Ting Han, et al. Science. Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15

[2] H Gao, et al. Cancer Res. Chloroquinoxaline sulfonamide (NSC 339004) is a topoisomerase IIalpha/beta poison

[3] R F Branda, et al. Biochem Pharmacol. Cellular pharmacology of chloroquinoxaline sulfonamide and a related compound in murine B16 melanoma cells

[4] R F Branda, et al. Biochem Pharmacol. Immunosuppressive properties of chloroquinoxaline sulfonamide

Related PROTAC Products
CR8

CR8 is a potent and selective inhibitor of cyclin dependent kinase (CDK1, 2, 5, 7, and 9).

ARV-393

ARV-393 is an orally active PROTAC degrader targeting BCL6 for studies related to diffuse large B-cell lymphoma. ARV-393 utilizes the ubiquitin-proteasome system to target the degradation of BCL6.

ARV-766

ARV-766 is an orally active and potent proteolysis targeting chimera (PROTAC) protein degrader. ARV-766 degrades wild-type androgen receptor (AR) but also relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations. ARV-766 has the potential to be first- and best-in class PROTAC AR degrader in mCRPC.

Indisulam

Indisulam is a carbonic anhydrase inibitor and antitumor CDK inhibitor. Indisulam targets the G1 phase of the cell cycle by depleting cyclin E. inducing p53 and p21, and inhibiting CDK2, causing a blockade in the G1/S transition.

dBET6

dBET6 is a highly potent, selective and cell-permeable PROTAC connected by ligands for Cereblon and BET, with an IC50 of 14 nM, and has antitumor activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: Chloroquinoxaline sulfonamide, Chloroquinoxaline; NSC-339004 supplier, PROTAC, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.